Published April 24, 2019
| Version v1
Journal article
Open
Re-Purification of ALK2 for crystallisation with different compounds from M4K.
Description
Cleaning up of a frozen purified sample of ALK2/ACVR1 by gel filtration after thawing for use in co-crystallisation trials with five M4K compounds (M4K2163, M4K2143, M4K2192, M4K2207 and M4K2194). You can read more about it on Open Lab Notebooks.
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
Re-Purification of ALK2 for crystallisation with different compounds from M4K.pdf
Files
(464.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:a8097f25f744581f0fcf866de096e844
|
464.0 kB | Preview Download |